[HTML][HTML] Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: Recent advances

W Wang, F Zhao, X Ma, G Perry, X Zhu - Molecular neurodegeneration, 2020 - Springer
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases,
characterized by impaired cognitive function due to progressive loss of neurons in the brain …

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

M Platten, EAA Nollen, UF Röhrig, F Fallarino… - Nature reviews Drug …, 2019 - nature.com
Abstract l-Tryptophan (Trp) metabolism through the kynurenine pathway (KP) is involved in
the regulation of immunity, neuronal function and intestinal homeostasis. Imbalances in Trp …

[HTML][HTML] Tryptophan metabolism in inflammaging: from biomarker to therapeutic target

FJH Sorgdrager, PJW Naudé, IP Kema… - Frontiers in …, 2019 - frontiersin.org
Inflammation aims to restore tissue homeostasis after injury or infection. Age-related decline
of tissue homeostasis causes a physiological low-grade chronic inflammatory phenotype …

[HTML][HTML] A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease

H Hampel, F Caraci, AC Cuello, G Caruso… - Frontiers in …, 2020 - frontiersin.org
Neuroinflammation commences decades before Alzheimer's disease (AD) clinical onset and
represents one of the earliest pathomechanistic alterations throughout the AD continuum …

Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation

PS Minhas, L Liu, PK Moon, AU Joshi, C Dove… - Nature …, 2019 - nature.com
Recent advances highlight a pivotal role for cellular metabolism in programming immune
responses. Here, we demonstrate that cell-autonomous generation of nicotinamide adenine …

[HTML][HTML] Alzheimer's disease, oligomers, and inflammation

G Forloni, C Balducci - Journal of Alzheimer's Disease, 2018 - content.iospress.com
The production of soluble amyloid-β oligomers (AβOs) and the activation of inflammation are
two important early steps in the pathogenesis of Alzheimer's disease (AD). The central role …

[HTML][HTML] The effect of insomnia on development of Alzheimer's disease

S Sadeghmousavi, M Eskian, F Rahmani… - Journal of …, 2020 - Springer
Alzheimer's disease (AD) is the most common type of dementia and a neurodegenerative
disorder characterized by memory deficits especially forgetting recent information, recall …

Interplay between inflammation and neural plasticity: both immune activation and suppression impair LTP and BDNF expression

MT Golia, S Poggini, S Alboni, S Garofalo… - Brain, Behavior, and …, 2019 - Elsevier
An increasing number of studies show that both inflammation and neural plasticity act as key
players in the vulnerability and recovery from psychiatric disorders and neurodegenerative …

[HTML][HTML] Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging

J Flores, A Noël, B Foveau, O Beauchet… - Nature …, 2020 - nature.com
Early therapeutic interventions are essential to prevent Alzheimer Disease (AD). The
association of several inflammation-related genetic markers with AD and the early activation …

Kynurenine pathway metabolites as biomarkers in Alzheimer's disease

Y Liang, S Xie, Y He, M Xu, X Qiao, Y Zhu… - Disease …, 2022 - Wiley Online Library
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that deteriorates
cognitive function. Patients with AD generally exhibit neuroinflammation, elevated beta …